1) So, this is the first 'serious' preclinical data I have seen for an actual vaccine candidate. This one is an inactivated SARS-CoV-2 vaccine made by Sinovac. Seems to work in NHPs. https://t.co/3znYhO2L7k

— Florian Krammer (@florian_krammer) April 22, 2020